1B. Pharm Scholar, Veerayatan Institute of Pharmacy, Jakhania, Gujarat, India
2Assistant Professor, Smt. R. D. Gardi B. Pharmacy College, Rajkot, Gujarat, India-360110.
Nanoparticles (NPs) are pervasive in our daily lives today as a result of the industry's rapid expansion in the previous ten years. Numerous nanomaterials have been created with medicinal applications in mind. One of these goals is pulmonary illness treatment. The use of colloidal drug delivery systems as drug carriers for the administration of various medications via various routes of administration has received substantial research. For a very long time, systems like polymeric nanoparticles, liposome, and solid lipid nanoparticles have been studied for the treatment of various lung ailments. It appears that nanoparticles could have dual impacts. When nanomaterials are used to develop medicines, their toxic consequences should be taken into account. In order to summarise the dual functions of nanoparticles in treating pulmonary disorders as well as the onset of lung diseases and even secondary diseases brought on by lung damage. We'll also talk about how these impacts are caused by factors like the physicochemical characteristics of nanoparticles.
Vaishvi Patel*, Megha Gandhi, Kajal Pradhan, An Overview Of Nanoparticles A Survey Of Characteristics, Advancements And Challenges, Int. J. in Pharm. Sci., 2023, Vol 1, Issue 9, 184-191. https://doi.org/10.5281/zenodo.8331480